Skip to main content
Home
  • Clinical Outcome Assessments
    Clinical Outcome Assessments

    What are Clinical Outcome Assessments (COAs)? What do they measure?

    Learn more about COAs
    hero_1.jpeg
    The most trusted distributor of COAs

    700+ exclusive COA distributions on behalf of their copyright owners

    hero_2.jpeg
    PROQOLID™: the largest COA database

    7,000+ COAs described in details and accessible in this unique database

  • Services
    Services

    Mapi Research Trust provides turnkey solutions for your Clinical Outcome Assessments (COAs) strategies - including COA databases, targeted literature reviews, licensing.

    Read More
    COA Databases Patient-Centered Endpoint Intelligence COA Licensing Translation and Linguistic Validation eCOA Licensing COA Repository
    hero_3.jpeg
    About ePROVIDE™

    Online access to all our services and COA databases

    hero_2_2.jpeg
    What are eBooklets?

    Find out more about this step-by-step guidance for valid digitization of COAs

  • Author Collaboration
    Author Collaboration

    Our team is dedicated to assisting authors in the daily management of their questionnaires and all derivatives, including translations and electronic versions

    Read More
    COA distribution COA copyright and protection Promotion of COAs and developers Testimonials
    hero_3_1.jpeg
    Catalog of COAs distributed by Mapi Research Trust

    800+ exclusive distributions of COAs, accessible in ePROVIDE

  • Resources
    Resources

    ACCESS all our resources on COAs and eCOA: webinars, publications, blogs. SUBSCRIBE to receive email updates.

    Read More
    Blog Publications Useful links Webinar recordings Whitepapers
    Whitepaper-Digitizing-COAs.jpg
    New whitepaper

    Digitizing COAs: A streamlined approach to approval

    hero_4_2.jpeg
    New whitepaper

    COAs and copyright: How to mitigate risks of infringement and misuse in clinical research and practice

  • News & Events
    News & Events

    Stay informed with our latest news and check all our upcoming events. SUBSCRIBE to get email updates.

    Read More
    hero_5_1.jpeg
    News
    Hero_5_2.jpeg
    Conferences
    Hero_5_3.jpeg
    Webinars
  • About us
    About us

    Mapi Research Trust is a non-profit organization dedicated to improving patients’ quality of life by facilitating access to Clinical Outcome Assessments(COAs).

    Read More
    hero_6_1.jpeg
    Team

    A global team of multi-disciplinary experts

    hero_6_2.jpeg
    Experience

    Collecting & Processing Patient Centered Outcomes information for more than two decades

  • Contact
  1. Home
  2. News & Events
  3. News
  4. Mapi Research Trust announces new distribution partnership with the Center for Environmental Therapeutics

Mapi Research Trust announces new distribution partnership with the Center for Environmental Therapeutics

uuid_5fa833e2-283a-4ce1-a152-a1adcb080263_CET-logo-green

Mapi Research Trust (MRT) is excited to announce a new partnership with the Center for Environmental Therapeutics (CET) for the distribution of its scales. The CET is an independent, non-profit organization dedicated to education and research on new environmental therapies. The Center is comprised of a multidisciplinary team of researchers and clinicians with expertise in mental health, ophthalmology and optical physics, lighting engineering, biochemistry and physiology.

MRT will manage the licensing, distribution, and coordination and development of translations and electronic versions of the CET’s scales. These scales include the following:

DIAD – Diagnostic Interview for Atypical Depression
SIGH-ADS – Structured Interview Guide for the Hamilton Depression Rating Scale with Atypical Depression Supplement
SIGH-SAD – Structured Interview Guide for the Hamilton Depression Rating Scale – Seasonal Affective Disorder
HIGH-C – Hypomania Interview Guide (Including Hyperthymia) – Current Assessment
HIGH-R – Hypomania Interview Guide (Including Hyperthymia) – Retrospective Assessment
MEQ-REV – Morningness-Eveningness Questionnaire, Revised

These instruments provide state-of-the-art structured interviews for clinicians to rate the severity of depression (including atypical symptoms) and hypomania, and self-rating versions for patients to complete for clinician review.

The SIGH-ADS, which includes 8 items focused on atypical depressive symptoms formulated at the U.S. National Institute of Mental Health, has been adopted in more than 70 research studies. In an online, interactive form of the MEQ-REV, over 2 million people have used the AutoMEQ on CET’s website to self-assess circadian rhythm phase as a guide for scheduling sleep and chronotherapy.

To access CET’s instruments, please submit a request through MRT’s ePROVIDE platform.

 

In this section
In this section
  • News
  • Events
    • Conferences
    • Webinars
Site Branding
    ICON plc
  • Contact
  • About Us
For Clients
  • Services
  • Resources
  • ePROVIDE™
News & Events
  • News
  • Conferences
  • Webinars
Socials
  • Linkedin

Legal Footer

  • © 2025 Mapi Research Trust
  • Disclaimer
  • Privacy
How can we help?
  • All
Popular search terms:
  • COVID-19
  • Site & Patient Recruitment
  • Oncology
  • Medical Device
  • Real World Evidence
  • Decentralised & hybrid clinical trials
  • Digital Disruption